No Prescription |
 |
 | ||
|
Diurin Lasix |
|
| ||
No Prescription » Prescription Drugs 6 » Diurin Lasix Furosemide a 'water pill ' is used to reduce the swelling and fluid retention caused by various medical problems including heart or liver disease. It is also used to treat high blood pressure. It causes the kidneys to get rid of unneeded water and salt from the body into the urine.Furosemide comes as a tablet and liquid to take by mouth. It usually is taken once a day in the morning or twice a day in the morning and afternoon. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take furosemide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Furosemide controls high blood pressure but does not cure it. Continue to take furosemide even if you feel well. Do not stop taking furosemide without talking to your doctor. Buy Diurin Lasix and other Prescription Drugs 6 products online at Medstore. 92
About Diurin Lasix: Product Type: Prescription Drugs 6 Diurin ( Lasix Generic Frusemide ) Diurin (Lasix Generic Frusemide) Lasix Generic Frusemide 40mg 1000 Tabs Lasix Generic Frusemide Diurin
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
